Modivcare and Michigan Center for Rural Health Launch Remote Patient Monitoring in Rural Hospitals
Modivcare Inc. (Nasdaq: MODV), a technology-enabled healthcare services company focused on improving health outcomes through integrated supportive care solutions, has successfully completed an 18-month Remote Patient Monitoring (RPM) pilot program.…
CDC’s ACIP Recommends Merck’s CAPVAXIVE™ Pneumococcal Vaccine for Adults 50+
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) has voted to update the pneumococcal vaccination guidelines…
AMRA® Profiler 4 Pilot Study Shows Feasible Muscle Composition Assessment in Liver Transplant Candidates
A recent study published in the Annals of Hepatology investigated the feasibility of using the AMRA® MAsS Scan, powered by the FDA-cleared AMRA® Profiler 4 device, to assess muscle composition…
Align Technology Launches Invisalign Smile Architect™ for Enhanced Ortho Restorative Options
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, has announced the…
XiFin Pharmacy Solutions Seeks Insights from Pharmacy Professionals on Future Care Success
This American Pharmacists Month, XiFin Pharmacy Solutions invites pharmacy professionals to join the 2025 Pharmacy Transformation Study, which aims to identify key success factors shaping the future of pharmacy care.…
14th Annual Spok Survey Reveals Insights on Healthcare Communications Challenges
Spok, Inc., a subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, has published its 14th annual survey on communication practices within U.S. healthcare organizations. This…
Otsuka Reports Positive Interim Phase 3 Results for Sibeprenlimab in Adult IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. have announced positive topline interim results from their ongoing Phase 3 clinical trial of sibeprenlimab for treating immunoglobulin A…
FDA Committee Backs CEL-SCI’s Multikine® for PD-L1 Negative Cancer Treatment
CEL-SCI Corporation (NYSE American: CVM) today highlighted the promising implications for its immunotherapy Multikine® (Leukocyte Interleukin, Injection) following a recent meeting of the U.S. Food and Drug Administration (FDA) Oncologic…
AMRA Study: Antidepressant Use Linked to Poor Muscle Health and Higher Cardiometabolic Risk
AMRA Medical, in collaboration with the University of Oslo, has published a study examining the effects of antidepressants (ADs), particularly serotonin-selective reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), on muscle…
Aptar Wins Federal Contract to Enhance Medical Device Sterilization Technology
AptarGroup, Inc. (NYSE: ATR), a global leader in dosing, dispensing, and protection technologies for drug and consumer products, has announced the award of a contract from the U.S. Federal Government…
FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for At-Risk Adults 18-59
Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), a bivalent RSV vaccine, for preventing lower respiratory tract disease…
Hello Heart Enters Government Markets for Public Servants and Their Families
Hello Heart, a leader in preventive heart health, has announced its expansion into government markets across the United States. This initiative aims to make its proven heart health tools accessible…